HAEMONETICS CORP/MASS (HAE) Stock Price, Quote, News and Summary

Company Profile

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,657 full-time employees. The firm is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.

Company Info

HAEMONETICS CORP/MASS

125 Summer Street

Boston MASSACHUSETTS 02110 US

CEO: Christopher A. Simon

Employees: 3657

Company Website: https://www.haemonetics.com

Investor Relations: https://haemonetics.gcs-web.com

Phone: 17818487100